EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Alzheimer´s disease blood biomarkers are associated with a higher risk for postoperative long‐term cognitive decline: Insights from the FINDERI study

Niels Hansen, Monika Sadlonova, Hermann Esselmann, Christopher M Celano, Carlotta Derad, Thomas Asendorf, Maike Hohberg, Mohammed Chebbok, Stephanie Heinemann, Barbara Morgado, Tobias Titsch, Katharina Packroß und 13 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Niels Hansen und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany. Hauptthemen laut MEDLINE: Biomarkers, Alzheimer Disease, Postoperative Cognitive Complications, Cardiac Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Heart Foundation/German Foundation, iBiMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The study aim is to investigate whether blood biomarkers (BBMs) of Alzheimer's disease (AD) pathology are associated with postoperative cognitive dysfunction (POCD) after cardiac surgery. METHODS Cognitive performance was assessed before and 12 months postoperatively using the Montreal Cognitive Assessment (MoCA) and categorized into stages—minimal (1), notable (2), and substantial (3) decline—in the FIND DElirium RIsk factors (FINDERI) study of patients undergoing cardiac surgery. BBMs were measured preoperatively (amyloid beta [Aβ]1‐42, Aβ1‐40, phosphorylated tau 181 [p‐tau181], p‐tau217, apolipoprotein E ε4 [apoE4] and apoE). RESULTS A total of 394 patients completed follow‐up investigations. POCD Stage 1 was observed in 105 (26.6%), POCD Stage 2 in 52 patients (13.2%), and POCD Stage 3 in 30 patients (7.6%). The AT 217 term (ratio Aβ1‐40/1‐42 * p‐tau217) was significantly associated with POCD stages in multiple logistic regression. DISCUSSION Early Alzheimer's BBMs are associated with POCD in patients, suggesting that our exploratory findings assessing BBMs may support risk stratification, inform decision‐making, and contribute to strategies aimed at preventing POCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersAlzheimer DiseasePostoperative Cognitive ComplicationsCardiac Surgical ProceduresCognitive DysfunctionPostoperative ComplicationsHumansFemaleMaletau ProteinsAmyloid beta-PeptidesAgedRisk FactorsPeptide FragmentsApolipoprotein E4Apolipoproteins ENeuropsychological Tests

Stichwörter der Autor:innen

Alzheimer´s diseaseblood biomarkerpostoperative cognitive dysfunction

Substanzen

Biomarkerstau ProteinsAmyloid beta-PeptidesPeptide FragmentsApolipoprotein E4amyloid beta-protein (1-40)Apolipoproteins E

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany.
  • Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany.
  • Department of Cardiovascular and Thoracic Surgery, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany.
  • Department of Geriatrics, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany.
  • German Center for Cardiovascular Research (DZHK), partner site Lower Saxony, , Germany.
  • Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.

Förderung

  • German Heart Foundation/German Foundation
  • iBiMED

Zitieren

APA

Hansen, N., Sadlonova, M., Esselmann, H., Celano, C. M., Derad, C., Asendorf, T., Hohberg, M., Chebbok, M., Heinemann, S., Morgado, B., Titsch, T., Packroß, K., Knopp, C. M., Becker, M. M., Günther, I., Krasiuk, I., Rediske, A. I., Süttmann, N. P., Itting, P. T., …, & FINDERI investigators (2026). Early Alzheimer´s disease blood biomarkers are associated with a higher risk for postoperative long‐term cognitive decline: Insights from the FINDERI study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71631

Vancouver

Hansen N, Sadlonova M, Esselmann H, Celano CM, Derad C, Asendorf T, et al. Early Alzheimer´s disease blood biomarkers are associated with a higher risk for postoperative long‐term cognitive decline: Insights from the FINDERI study. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71631

BibTeX
@article{Hansen2026,
  author = {Hansen, Niels and Sadlonova, Monika and Esselmann, Hermann and Celano, Christopher M and Derad, Carlotta and Asendorf, Thomas and Hohberg, Maike and Chebbok, Mohammed and Heinemann, Stephanie and Morgado, Barbara and Titsch, Tobias and Packroß, Katharina and Knopp, Clara Maria and Becker, Matilda-Marie and Günther, Irina and Krasiuk, Iryna and Rediske, Alina Isabel and Süttmann, Nicholas Paul and Itting, Paul Thomas and Wirths, Oliver and Kutschka, Ingo and Baraki, Hassina and von Arnim, Christine A F and Wiltfang, Jens and FINDERI investigators, FINDERI investigators},
  title = {Early Alzheimer´s disease blood biomarkers are associated with a higher risk for postoperative long‐term cognitive decline: Insights from the FINDERI study},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71631}
}
Kostenlos starten →